Blocking Formation Of Toxic Plaques Implicated In Type 2 Diabetes

Amid growing evidence that the same abnormal clumping of proteins in Alzheimer's disease also contributes to type-2 diabetes, scientists are reporting discovery of a potent new compound that reduces formation of those so-called amyloid plaques. The report cites evidence correlating increases in amyloid formation in the pancreas with increases in severity and rate of progression of type-2 diabetes, which affects almost 20 million Americans and is rapidly rising worldwide.